In the latest episode of the weekly ABA Pandemic Update podcast, ABA SVP Paul Benda discusses bad news on rising case counts, new data on contagiousness of the Delta variant of COVID-19, vaccination protection timelines, vaccine booster shot and treatment news and an update on the Occupational Safety and Health Administration's emergency temporary standard.

In the latest episode of the weekly Pandemic Update podcast, ABA SVP Paul Benda discusses new data on recovered immunity, vaccines for children and a new study on Ivermectin. Benda also talks with ABA SVP Jonathan Thessin about the Occupational Safety and Health Administration's emergency temporary standard that will require all employers with 100 or more employees to be fully vaccinated or test weekly for COVID-19.

ABA SVP Paul Benda discusses the FDA review of children vaccines, booster shot data, predictions for the future and the factors that will affect it such as recovered immunity durability. He also talks about the new Delta plus variant and what to know about other "scariants."

On the latest episode of the ABA Pandemic Update podcast, ABA SVP Paul Benda discusses a recent visit to Universal Studios, current case trends, booster approvals, timelines and mixing and matching, and what does it mean to live with COVID.

On the latest episode of the ABA Pandemic Update podcast, ABA SVP Paul Benda discusses our declining cases, examines how they correspond to other countries' Delta variant wave as well as the 1918 flu pandemic, compares recovered immunity and vaccinated immunity, looks at booster schedules for Moderna, Johnson and Johnson (as well as approval for children's vaccines) and touches on vaccine mandates and religious exemptions.

ABA SVP Paul Benda discusses the continued downward trend in COVID cases and what the fancy models predict, provides an update on vaccines for kids, discusses boosters (and mixing and matching vaccines), reviews a new report on surface contamination, and evaluates where we stand on OSHA's emergency temporary standards and whether most banks considered federal contractors for purposes of the Biden administration's vaccine and testing mandate.

ABA SVP Paul Benda discusses a slight downturn in COVID cases, Pfizer data from its vaccine trial for kids, the risk of myocarditis from vaccines, booster shots for Pfizer and Johnson & Johnson and some good news on "long COVID."

ABA SVP Paul Benda discusses coronavirus case rates in kids, drivers for infection and when their vaccine may be available; the value and efficacy of home tests; the pending availability of booster shots; and a quick review of the Biden COVID-19 "action plan."

Recorded slightly later in the week to account for Labor Day-related reporting delays, ABA SVP Paul Benda discusses the plateau seen in national COVID-19 case counts (and the case decline in several states that saw Delta variant surges), examines the rise in the proportion of cases that are due to children getting infected and does a deep dive into ivermectin in response to listener questions.

ABA SVP Paul Benda discusses potential vaccine booster shot plans, risk and benefit calculations for vaccinating 5-12-year-olds, an unmasked teacher in California who gave the virus to half of her students, testing trends and just what is going on with Ivermectin.